Methylphenidate ER Clinical Trials

• Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning
  ClinicalTrials.gov Identifier: NCT00418691 - Recruiting
  Brain Tumor
  
• Ritaline
  ClinicalTrials.gov Identifier: NCT00273741 - Recruiting
  Palliative Care; Asthenia; Neoplasms; Methylphenidate
  
• A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00302458 - Recruiting
  Healthy
  
• Multiphase Efficacy Study of venlafaxine ER to Treat Recurrent Depression
  ClinicalTrials.gov Identifier: NCT00046020 - Active, not recruiting
  Depression
  
• Methylphenidate in the Treatment of Cocaine Dependent Patients with Adult Attention Deficit Hyperactivity Disorder - 5
  ClinicalTrials.gov Identifier: NCT00015223 - Active, not recruiting
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Study Examining Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate Release Methylphenidate in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00302393 - Not yet recruiting
  Healthy
  
• Methylphenidate Treatment for Cocaine Abuse and ADHD - 1
  ClinicalTrials.gov Identifier: NCT00136734 - Active, not recruiting
  Attention Deficit Disorder with Hyperactivity; Cocaine-Related Disorders
  
• Methylphenidate in Treating Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00003266 - Active, not recruiting
  unspecified adult solid tumor, protocol specific; Fatigue; Quality of Life
  
• The Genetic Bases for Vulnerability to Substance Abuse in Individuals With Different Acute Responses to Methylphenidate
  ClinicalTrials.gov Identifier: NCT00247689 - Not yet recruiting
  Substance Abuse
  
• Safety and Tolerability of MTS in Children Aged 6-12 Diagnosed with ADHD and Previously Treated with Extended-Release Methylphenidate Therapy
  ClinicalTrials.gov Identifier: NCT00151983 - Completed
  Attention Deficit Disorder with Hyperactivity
  
• Study of DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00087737 - Active, not recruiting
  Major Depressive Disorder
  
• Study Of DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00090649 - Active, not recruiting
  Major Depressive Disorder
  
• Methylphenidate for Apathy in Alzheimer’s Dementia: A Controlled Study
  ClinicalTrials.gov Identifier: NCT00495820 - Not yet recruiting
  ALZHEIMER’S DISEASE; APATHY; Dementia; Methylphenidate
  
• Methylphenidate for Depressed Cancer Patients in Hospice
  ClinicalTrials.gov Identifier: NCT00129467 - Recruiting
  Depression; Hospice Care; Cancer; Mental Disorder
  
• Cetuximab and Carbo for ER/PR/HER2 Negative BC
  ClinicalTrials.gov Identifier: NCT00420329 - Active, not recruiting
  Breast Cancer
  
• Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00329186 - Active, not recruiting
  Depressive Disorder, Major
  
• Methylphenidate for Treating Children With ADHD and Tourette Syndrome
  ClinicalTrials.gov Identifier: NCT00441649 - Active, not recruiting
  Attention Deficit Disorder With Hyperactivity; Tourette Syndrome
  
• The Effect of Methylphenidate on Motor Learning in Stroke Patients
  ClinicalTrials.gov Identifier: NCT00396058 - Recruiting
  Cerebrovascular Accident
  
• Preoperative Cisplatin in Early Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00148694 - Active, not recruiting
  Breast Cancer; ER Negative Breast Cancer; PR Negative Breast Cancer; HER-2 Negative Breast Cancer
  
• An Open-Label Study of Quetiapine Added to Oros Methylphenidate in the Treatment of ADHD and Aggressive Behavior
  ClinicalTrials.gov Identifier: NCT00198211 - Active, not recruiting
  Attention-Deficit/Hyperactivity Disorder, Combined Type; Disruptive Behavior Disorder
  
• Methylphenidate Study in Young Children With Developmental Disorders
  ClinicalTrials.gov Identifier: NCT00517504 - Recruiting
  Attention Deficit Hyperactivity Disorder
  
• Risperidone Vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression
  ClinicalTrials.gov Identifier: NCT00179244 - Active, not recruiting
  Unipolar Depression
  
• A Case Management Intervention to Prevent ER Visits in HIV-Infected Persons
  ClinicalTrials.gov Identifier: NCT00187590 - Active, not recruiting
  HIV
  
• A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00396565 - Active, not recruiting
  Schizophrenia
  
• Depakote-ER for Depressive and Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00226343 - Active, not recruiting
  Bipolar Disorder
  
• Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD
  ClinicalTrials.gov Identifier: NCT00506285 - Recruiting
  Attention Deficit Hyperactivity Disorder
  
• Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1
  ClinicalTrials.gov Identifier: NCT00061087 - Active, not recruiting
  Opioid-Related Disorders
  
• Genetic Measurements in Blood Cells of Children Taking Adderall or Methylphenidate
  ClinicalTrials.gov Identifier: NCT00341029 - Recruiting
  Attention Deficit Hyperactivity Disorder; ADHD
  
• Double-Blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression
  ClinicalTrials.gov Identifier: NCT00194116 - Active, not recruiting
  Bipolar Disorder
  
• Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-Menopausal Patients
  ClinicalTrials.gov Identifier: NCT00303524 - Active, not recruiting
  Breast Cancer
  
• Efficacy Study of PR OROS Methylphenidate and Psychosocial Interventions in Swedish Imprisoned Men With ADHD
  ClinicalTrials.gov Identifier: NCT00482313 - Recruiting
  Attention Deficit Hyperactivity Disorder
  
• A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00326300 - Active, not recruiting
  Attention Deficit Hyperactivity Disorder
  
• A Double-Blind Randomized, Placebo-Controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-Acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00302354 - Completed
  Healthy Volunteers
  
• An Effectiveness and Safety Study of CONCERTA* Vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children
  ClinicalTrials.gov Identifier: NCT00304681 - Active, not recruiting
  Attention Deficit Hyperactivity Disorder
  
• Methylphenidate and a Nursing Telephone Intervention for Fatigue
  ClinicalTrials.gov Identifier: NCT00424099 - Recruiting
  Advanced Cancer; Fatigue
  
• Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00199966 - Active, not recruiting
  Bipolar Disorder
  
• Study of the Effects of OROS Methylphenidate (Concerta) on Attention and Memory
  ClinicalTrials.gov Identifier: NCT00530257 - Recruiting
  Attention Deficit Hyperactivity Disorder
  
• Pediatric Traumatic Brain Injury: Methylphenidate Effects on Early Recovery
  ClinicalTrials.gov Identifier: NCT00035139 - Completed
  Brain Injuries
  
• Paliperidone ER Study of Economic, Functional, and Clinical Outcomes.
  ClinicalTrials.gov Identifier: NCT00488891 - Recruiting
  Schizophrenia
  
• Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
  ClinicalTrials.gov Identifier: NCT00501293 - Recruiting
  ADHD
  
• Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00409708 - Active, not recruiting
  Attention Deficit Hyperactivity Disorder
  
• Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00511953 - Active, not recruiting
  Hot Flashes
  
• Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
  ClinicalTrials.gov Identifier: NCT00499863 - Recruiting
  ADHD
  
• Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
  ClinicalTrials.gov Identifier: NCT00202514 - Active, not recruiting
  Alcoholism; Alcohol Related Disorders; Mood Disorders
  
• Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00181727 - Active, not recruiting
  Bipolar Disorder; Mania
  
• Brief Intervention to Reduce STDs in ER Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00218400 - Recruiting
  Substance-Related Disorders; Sexual Risk Behaviors
  
• Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00393562 - Recruiting
  Parkinson's Disease
  
• A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-Release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00309686 - Active, not recruiting
  Affective Psychosis, Bipolar; Bipolar Disorder; Mania
  
• Naturalistic Study, Comparison of Divalproex ER and Quetiapine for Adults With Acute Mania or Mixed Episodes
  ClinicalTrials.gov Identifier: NCT00397020 - Recruiting
  Bipolar Disorder
  
• NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate
  ClinicalTrials.gov Identifier: NCT00169611 - Recruiting
  Neurofibromatosis Type 1
  
• Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
  ClinicalTrials.gov Identifier: NCT00453921 - Recruiting
  Brain Injury
  
• A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-Release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00309699 - Active, not recruiting
  Bipolar Disorder; Mood Disorders
  
• Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed with ADHD
  ClinicalTrials.gov Identifier: NCT00151970 - Completed
  Attention Deficit Disroder with Hyperactivity
  
• Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ER.
  ClinicalTrials.gov Identifier: NCT00211250 - Recruiting
  Mood Disorder
  
• Depakote ER in Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00186186 - Active, not recruiting
  Depression, Bipolar
  
• Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed with ADHD and Previously Participated in MTS Trials
  ClinicalTrials.gov Identifier: NCT00151957 - Completed
  Attention Deficit Disorder with Hyyperactivity.
  
• Study to Measure the Safety of Paliperidone ER (Extended-Release) in Patients With Liver Disease
  ClinicalTrials.gov Identifier: NCT00535145 - Recruiting
  Schizophrenia; Psychotic Disorders; Schizoaffective Disorder
  
• Panic Disorder Study
  ClinicalTrials.gov Identifier: NCT00038896 - Active, not recruiting
  Panic Disorder
  
• Panic Disorder Study
  ClinicalTrials.gov Identifier: NCT00044772 - Active, not recruiting
  Panic Disorder
  
• Evaluate the Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children Following Discharge From the ER/Outpatient Care Facility
  ClinicalTrials.gov Identifier: NCT00189436 - Recruiting
  Asthma
  
• Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD
  ClinicalTrials.gov Identifier: NCT00305370 - Recruiting
  Bipolar Disorder; Attention Deficit Hyperactivity Disorder
  
• Methylphenidate Study in Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00516269 - Recruiting
  Breast Cancer; Fatigue
  
• Tolerability and Efficacy of Depakote-ER in the Elderly
  ClinicalTrials.gov Identifier: NCT00318929 - Recruiting
  Elderly; Epilepsy; Seizures
  
• Study of Paliperidone ER in Adolescents and Young Adults With Autism
  ClinicalTrials.gov Identifier: NCT00549562 - Recruiting
  Autism
  
• Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00525135 - Recruiting
  Head and Neck Cancer
  
• An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00473434 - Recruiting
  Schizophrenia
  
• A Study of the Efficacy and Safety of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00524043 - Recruiting
  Schizophrenia
  
• Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-Release (ER) for Hypertension
  ClinicalTrials.gov Identifier: NCT00547300 - Recruiting
  Hypertension
  
• Divalproex Sodium ER in Adult Autism
  ClinicalTrials.gov Identifier: NCT00211796 - Recruiting
  Autism
  
• A Trial to Explore the Tolerability, Safety and Effectiveness of Paliperidone ER (Extended Release) Flexible Dosing in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00460512 - Recruiting
  Schizophrenia
  
• Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
  ClinicalTrials.gov Identifier: NCT00315900 - Recruiting
  Agitation; Dementia
  
• A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients.
  ClinicalTrials.gov Identifier: NCT00518323 - Recruiting
  Schizophrenia
  
• A Multicenter Study Comparing the Efficacy and Safety of OROS® Methylphenidate HCl, Ritalin® (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00269802 - Completed
  Attention Deficit Hyperactivity Disorder
  
• A Comparative Effectiveness Study Evaluating OROS® Methylphenidate HCl, Ritalin® (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children
  ClinicalTrials.gov Identifier: NCT00269789 - Completed
  Attention Deficit Hyperactivity Disorder
  
• A Trial to Explore the Tolerability, Safety and Treatment Response of the Antipsychotic Paliperidone ER (Extended Release) Using Flexible Dosing in Patients With Acute Schizophrenia
  ClinicalTrials.gov Identifier: NCT00566631 - Recruiting
  Schizophrenia
  
• Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics
  ClinicalTrials.gov Identifier: NCT00505531 - Recruiting
  Chronic Pain
  
• An Effectiveness and Safety Study Evaluating OROS® Methylphenidate HCl, Ritalin® (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00269776 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence
  ClinicalTrials.gov Identifier: NCT00204503 - Active, not recruiting
  Bipolar I or II Depression and Alcohol Abuse or Dependence
  
• Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients
  ClinicalTrials.gov Identifier: NCT00479401 - Recruiting
  Parkinson Disease
  
• Preoperative Cisplatin and Bevacizumab in ER-, PR-, Her-2 Negative Breast Cancer
  ClinicalTrials.gov Identifier: NCT00580333 - Recruiting
  Breast Cancer
  
• Trial Evaluating the Safety and Efficacy of 2 Doses of ER OROS Paliperidone in Acute Adult Schizophrenics
  ClinicalTrials.gov Identifier: NCT00077714 - Completed
  Schizophrenia
  
• Methylphenidate in Treating Patients With Fatigue Caused by Cancer
  ClinicalTrials.gov Identifier: NCT00376675 - Not yet recruiting
  Fatigue; Unspecified Adult Solid Tumor, Protocol Specific
  
• Open-Label Study of Flexible-Dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
  ClinicalTrials.gov Identifier: NCT00488319 - Recruiting
  Dementia Praecox.; Schizophrenia; Psychotic Disorders; Schizophrenic Disorders
  
• ADHD in Adolescents With Substance Use Disorders
  ClinicalTrials.gov Identifier: NCT00264797 - Recruiting
  ADHD; Substance Abuse
  
• An Open-Label Extension Study With Flexible Dosing of Extended-Release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain
  ClinicalTrials.gov Identifier: NCT00487435 - Recruiting
  Low Back Pain; Pain; Osteoarthritis
  
• Phase II Letrozole + Herceptin in Her2neu Positive, ER and/or PR Receptor (+),Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00134680 - Active, not recruiting
  Metastatic breast cancer
  
• Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11
  ClinicalTrials.gov Identifier: NCT00015301 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Treatment of Youth with ADHD and Anxiety
  ClinicalTrials.gov Identifier: NCT00012584 - Active, not recruiting
  Attention Deficit Hyperactivity Disorder; Anxiety, Separation; Social Phobia; Generalized Anxiety Disorder
  
• Testing Methylphenidate for Smoking Abstinence
  ClinicalTrials.gov Identifier: NCT00549640 - Not yet recruiting
  Smoking
  
• Breathing Meditation With Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00310986 - Recruiting
  Attention Deficit Disorder With Hyperactivity
  
• A 12-Week Study of Pramipexole ER in Patients With Parkinson?s Disease, Followed by a 52-Week Long-Term Treatment Period
  ClinicalTrials.gov Identifier: NCT00560508 - Recruiting
  Parkinson Disease
  
• Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00303615 - Recruiting
  Metastatic Breast Cancer
  
• A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
  ClinicalTrials.gov Identifier: NCT00449176 - Recruiting
  Low Back Pain
  
• An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)
  ClinicalTrials.gov Identifier: NCT00465088 - Recruiting
  Hyperlipidemia; Mixed Dyslipidemia
  
• Phase II Trial of Cetuximab Alone and in Combination With Carboplatin in ER-Negative, PR-Negative, HER-2 Nonoverexpressing Metastatic Breast Cancers (LCCC 0403)
  ClinicalTrials.gov Identifier: NCT00492375 - Recruiting
  Metastatic Breast Cancer
  
• Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?
  ClinicalTrials.gov Identifier: NCT00306475 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease
  ClinicalTrials.gov Identifier: NCT00558025 - Recruiting
  Parkinson Disease
  
• Trial of Letrozole Plus OSI-774 (Tarceva) in Post-Menopausal Women With Estrogen Receptor (ER) and/or Progesterone Receptor (PR)-Positive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00179296 - Recruiting
  Breast Cancer; Neoplasm Metastasis
  
• A Phase III Trial to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
  ClinicalTrials.gov Identifier: NCT00421928 - Recruiting
  Pain; Osteoarthritis, Knee
  
• Methylphenidate in ADHD With Trichotillomania
  ClinicalTrials.gov Identifier: NCT00552266 - Recruiting
  ADHD; Trichotillomania